OTC-PINK:ATMFF

ATMOFIZER TECHNOLOGIES INC. ANNOUNCES FOX NEWS INTERVIEWS WITH BOARD MEMBER DR JOSHUA HELMAN

Retrieved on: 
Wednesday, July 5, 2023
Fox News, Heart, HVAC, Liver, Hair, OTCQB, CSE, Brain, Atmosphere, Fox Business

Dr. Helman appeared as an air quality expert on these shows.

Key Points: 
  • Dr. Helman appeared as an air quality expert on these shows.
  • Dr. Helman was also able to highlight the benefits of Atmofizer's technology to agglomerate ultra fine particles like those that can be found in wildfire smoke.
  • Quote from Dr. Joshua Helman "The current wildfire smoke in the air is quite dangerous as it includes fine particulate that can be inhaled that can be absorbed in the lungs.
  • Links to Dr. Helman's interviews can be found below.

ATMOFIZER TECHNOLOGIES INC. ANNOUNCES BUSINESS UPDATE AND FIRST QUARTER 2023 INTERIM FINANCIAL RESULTS

Retrieved on: 
Tuesday, May 30, 2023
Treasury, Season, Business development, CSE, Particle aggregation, RSU, FINANCIAL, Air conditioning, Bank statement, Four Seasons, OTCQB, United States patent law, A500, HVAC, Patent, Indian stock exchange, Filtration, Heat, Cryptocurrency, Bank

VANCOUVER, BC, May 30, 2023 /PRNewswire/ - Atmofizer Technologies Inc. (the "Company" or "Atmofizer") (CSE: ATMO) (OTCQB: ATMFF) is pleased to announce its interim financial results for the three months ending March 31, 2023.

Key Points: 
  • VANCOUVER, BC, May 30, 2023 /PRNewswire/ - Atmofizer Technologies Inc. (the "Company" or "Atmofizer") (CSE: ATMO) (OTCQB: ATMFF) is pleased to announce its interim financial results for the three months ending March 31, 2023.
  • The Company continues to transition the business to its most valuable addressable market to integrate the agglomeration technology into existing forced air systems.
  • During the first quarter of 2023, the Company further refined its prototype design to maximize its agglomeration performance for its HVAC application.
  • FINANCIAL HIGHLIGHTS FOR THREE MONTHS ENDED MARCH 31, 2023
    Revenue for the first quarter of 2023 was $600 compared to $210,000 in the prior period.

ATMOFIZER TECHNOLOGIES INC. ANNOUNCES YEAR END 2022 FINANCIAL RESULTS

Retrieved on: 
Monday, May 1, 2023
Treasury, Patent, Season, Intellectual property, CSE, Particle aggregation, RSU, FINANCIAL, Atmosphere, Marketing, Bank statement, United States Patent and Trademark Office, Four Seasons, OTCQB, United States patent law, Water purification, Research, Sale, HVAC, ATM, Prospectus, Indian stock exchange, Standby Equity Distribution Agreement, Filtration, Asset, Heat, 1836 U.S. Patent Office fire, Cryptocurrency, Security (finance), Pharmaceutical industry, Heating, ventilation, and air conditioning

VANCOUVER, BC, May 1, 2023 /PRNewswire/ - Atmofizer Technologies Inc. (the "Company" or "Atmofizer") (CSE: ATMO) (OTCQB: ATMFF) is pleased to announce its financial results for the year ended December 31, 2022.

Key Points: 
  • VANCOUVER, BC, May 1, 2023 /PRNewswire/ - Atmofizer Technologies Inc. (the "Company" or "Atmofizer") (CSE: ATMO) (OTCQB: ATMFF) is pleased to announce its financial results for the year ended December 31, 2022.
  • The volume and timing of distributions under the ATM Program, if any, will be determined in the Company's sole discretion.
  • On April 5, 2022, the United States Patent and Trademark Office (the "USPTO") issued a U.S. Patent relating to the Company's air and water purification technology.
  • The U.S. Patent provides protection for the application of the Company's air and water purification technology in the United States.

ATMOFIZER TECHNOLOGIES INC. EFFECTIVE DATE FOR SHARE CONSOLIDATION

Retrieved on: 
Monday, January 9, 2023
Odyssey, OTCQB, Canadian Securities Exchange, Consolidation, News, Indian stock exchange, CSE, Letter, Exercise, Effectiveness, Effective date, DRS, CUSIP, Security (finance)

VANCOUVER, BC, Jan. 9, 2023 /PRNewswire/ - Atmofizer Technologies Inc. (the "Company" or "Atmofizer") (CSE: ATMO) (Frankfurt: J3K) (OTCQB: ATMFF) further to its news release of January 3, 2023, effective at the opening of trading on January 12, 2023 (the "Effective Date") the common shares of the Company (the "Common Shares") will commence trading on the Canadian Securities Exchange on a consolidated basis, with one (1) post-consolidated Common Share outstanding for every twenty (20) pre-consolidated Common Shares (the "Consolidation").

Key Points: 
  • VANCOUVER, BC, Jan. 9, 2023 /PRNewswire/ - Atmofizer Technologies Inc. (the "Company" or "Atmofizer") (CSE: ATMO) (Frankfurt: J3K) (OTCQB: ATMFF) further to its news release of January 3, 2023, effective at the opening of trading on January 12, 2023 (the "Effective Date") the common shares of the Company (the "Common Shares") will commence trading on the Canadian Securities Exchange on a consolidated basis, with one (1) post-consolidated Common Share outstanding for every twenty (20) pre-consolidated Common Shares (the "Consolidation").
  • As a result of the Consolidation, on the Effective Date, a total of approximately 6,687,390 Common Shares will be issued and outstanding, subject to adjustments for rounding, with approximately 489,207 Common Shares reserved for issuance.
  • No fractional Common Shares will be issued, and any post-Consolidation fraction of a Common Share will be rounded to the nearest whole number of Common Shares.
  • The exercise or conversion price and the number of Common Shares issuable under any of the Company's outstanding convertible instruments will be proportionately adjusted upon the effectiveness of the Consolidation.

ATMOFIZER TECHNOLOGIES INC. ANNOUNCES HVAC MARKET DEVELOPMENT AND THIRD QUARTER 2022 FINANCIAL RESULTS

Retrieved on: 
Tuesday, November 29, 2022
Marketing, COVID-19, Science, Water purification, Policy, Nature, Food, Gram-negative bacteria, United States patent law, Bacteria, FINANCIAL, Coronavirus, Surrogate, Air purifier, Regulation of tobacco by the U.S. Food and Drug Administration, HEPA, Particle aggregation, Autoclave, ATM, Patent, HVAC, SEDAR, Indian stock exchange, Gram-positive bacteria, Sale, Virus, Procurement, Health, Research, Atmosphere, Intellectual property, Risk, CSE, Severe acute respiratory syndrome coronavirus 2, Filtration, FDA, Heating, ventilation, and air conditioning, Pharmaceutical industry, Cryptocurrency, Risk management

VANCOUVER,BC, Nov. 29, 2022 /PRNewswire/ - Atmofizer Technologies Inc.(the"Company"or"Atmofizer") (CSE: ATMO) (Frankfurt: J3K)(OTCQB: ATMFF) is pleased to announce its recent progress in developing its technology for the HVAC market and its financial results for the quarter ended September 30, 2022.

Key Points: 
  • VANCOUVER,BC, Nov. 29, 2022 /PRNewswire/ - Atmofizer Technologies Inc.(the"Company"or"Atmofizer") (CSE: ATMO) (Frankfurt: J3K)(OTCQB: ATMFF) is pleased to announce its recent progress in developing its technology for the HVAC market and its financial results for the quarter ended September 30, 2022.
  • The design can be easily adapted to expand beyond the residential HVAC market to service commercial, industrial and agricultural applications.
  • The HVAC solution has been designed to scale to other HVAC applications with an asset light strategy that will target existing HVAC suppliers and manufacturers with existing distribution and scale.
  • The Company plans to market this patent to be licensed by air purification device manufacturers, HVAC suppliers and service companies.

ATMOFIZER TECHNOLOGIES INC. ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS

Retrieved on: 
Monday, August 29, 2022

VANCOUVER, BC, Aug. 29, 2022 /PRNewswire/ - Atmofizer Technologies Inc.(the"Company"or"Atmofizer") (CSE: ATMO) (Frankfurt: J3K)(OTCQB: ATMFF) is pleased to announce its financial results for the quarter ended June 30, 2022.

Key Points: 
  • VANCOUVER, BC, Aug. 29, 2022 /PRNewswire/ - Atmofizer Technologies Inc.(the"Company"or"Atmofizer") (CSE: ATMO) (Frankfurt: J3K)(OTCQB: ATMFF) is pleased to announce its financial results for the quarter ended June 30, 2022.
  • The program enables Atmofizer customers to acquire Atmofizer nanoparticle reduction air purifiers for less than one dollar per day.
  • The Company expects initial orders to begin by the third quarter of 2022, with revenue to be generated by the fourth quarter of 2022.
  • "The Company achieved a number of important technology development milestones during the second quarter of 2022.

ATMOFIZER TECHNOLOGIES INC. Announces LATEST Independent test results

Retrieved on: 
Thursday, August 25, 2022
Phrase, COVID-19, Technology, View, Virus, Risk, Food, Surrogate, Food and Drug Administration, HEPA, Atmosphere, Patent, Multimedia, Severe acute respiratory syndrome coronavirus 2, Company, FDA, SEDAR, Intellectual property, Industry, Health, Bacteria, Efficiency, Nature, Risk management

The Food and Drug Administration (FDA) has not evaluated Atmofizer technology.

Key Points: 
  • The Food and Drug Administration (FDA) has not evaluated Atmofizer technology.
  • Atmofizer ONE has not been reviewed or approved by the FDA.
  • Atmofizer's consumer and industrial solutions are based on its patent-protected and patent pending technology for ultrafine particle agglomeration and neutralization.
  • Atmofizer plans to disrupt the air treatment industry by improving air safety and purification efficiency while lowering customers' operational costs.

ATMOFIZER TECHNOLOGIES INC. RECEIVES NOTICE OF ALLOWANCE FROM USPTO

Retrieved on: 
Tuesday, August 23, 2022
Grandview, Phrase, COVID-19, Technology, CSE, Water purification, HVAC, United States Patent and Trademark Office, Commercial, Government, Patent, Filtration, Virus, USPTO, USD, United States patent law, Risk, Nanoparticle, Atmosphere, HEPA, Particle aggregation, Central heating, A500, Climate, Company, Filter (signal processing), SEDAR, Intellectual property, Industry, Health, Bacteria, Efficiency, Nature, Heating, ventilation, and air conditioning, Risk management, Ventilation, BC

VANCOUVER, BC, Aug. 23, 2022 /PRNewswire/ - Atmofizer Technologies Inc.(the "Company" or"Atmofizer") (CSE: ATMO) (Frankfurt: J3K)(OTCQB: ATMFF) announced today that the United States Patent and Trademark Office (the "USPTO") has issued a Notice of Allowance for new claims related to the Company's air and water purification technology.

Key Points: 
  • VANCOUVER, BC, Aug. 23, 2022 /PRNewswire/ - Atmofizer Technologies Inc.(the "Company" or"Atmofizer") (CSE: ATMO) (Frankfurt: J3K)(OTCQB: ATMFF) announced today that the United States Patent and Trademark Office (the "USPTO") has issued a Notice of Allowance for new claims related to the Company's air and water purification technology.
  • The recent Notice of Allowance from the USPTO is directed to a new design that delivers ultra-fine particle agglomeration and nanoparticle reduction performance in larger air ducts with faster-moving air, using less parts.
  • The Company plans to market this patent to be licensed by air purification device manufacturers, HVAC suppliers and service companies.
  • Atmofizer plans to disrupt the air treatment industry by improving air safety and purification efficiency while lowering customers' operational costs.

ATMOFIZER PROVIDES CORPORATE UPDATE ON FIRST QUARTER REPORTING AND CLEAN AIR TECHNOLOGY

Retrieved on: 
Tuesday, May 31, 2022
Company, HVAC, Fear, Public sector, Science, SEDAR, Nature, COVID-19, Efficiency, CSE, Industry, Intellectual property, Atmosphere, Safety, Technology, Risk, Phrase, CEO, Heating, ventilation, and air conditioning, Risk management, BC

VANCOUVER, BC, May 31, 2022 /PRNewswire/ - Atmofizer Technologies Inc.(the "Company" or"Atmofizer") (CSE: ATMO) (Frankfurt: J3K)(OTCQB: ATMFF) is pleased to announce a corporate update on its clean air technology.

Key Points: 
  • VANCOUVER, BC, May 31, 2022 /PRNewswire/ - Atmofizer Technologies Inc.(the "Company" or"Atmofizer") (CSE: ATMO) (Frankfurt: J3K)(OTCQB: ATMFF) is pleased to announce a corporate update on its clean air technology.
  • Olivier Centner, CEO of Atmofizer stated, "I'm extremely proud of the hard work we achieved this quarter across all departments.
  • The importance of clean air at home and at work is front of mind for governments and the public, and we have seen a wave of new clean air regulations.
  • Atmofizer is well positioned as a new and innovative technology to bring a proven technology to the market and capitalize on the opportunity.

ATMOFIZER TECHNOLOGIES INC. ANNOUNCES FIRST QUARTER 2022 FINANCIAL RESULTS

Retrieved on: 
Monday, May 30, 2022
1836 U.S. Patent Office fire, Program, Company, Patent, EBITDA, International, HVAC, FINANCIAL, Public relations, Smoke, Water purification, Personal protective equipment, Mission statement, Steinbrenner, MSRP, Standby Equity Distribution Agreement, Marketing, Adjustment, Research, EMC, ATM, CSE, Industry, Infection, Sponsor (commercial), Time, Atmosphere, Technology, Safety, Sale, United States patent law, IFRS, The, Treasury, Filter (signal processing), School, International Financial Reporting Standards, Acquisition, LLC, Prospectus, Bank, Cryptocurrency, Pharmaceutical industry, Online gambling, Bookkeeping, Daytona, BC

VANCOUVER, BC, May 30, 2022 /PRNewswire/ -Atmofizer Technologies Inc.(the "Company" or"Atmofizer") (CSE: ATMO) (Frankfurt: J3K)(OTCQB: ATMFF) is pleased to announce its financial results for the quarter ended March 31, 2022.

Key Points: 
  • VANCOUVER, BC, May 30, 2022 /PRNewswire/ -Atmofizer Technologies Inc.(the "Company" or"Atmofizer") (CSE: ATMO) (Frankfurt: J3K)(OTCQB: ATMFF) is pleased to announce its financial results for the quarter ended March 31, 2022.
  • On May 11, 2022, the Company announced test results of its airborne nanoparticle agglomeration engine.
  • The program will enable Atmofizer customers to acquire Atmofizer nanoparticle reduction air purifiers for less than one dollar per day.
  • The Company expects initial orders to begin by the third quarter of 2022, with revenue to be generated by the fourth quarter of 2022.